As America’s aging Baby Boomers start to crack open their nest eggs in retirement, there’s speculation that they will use the ...
Fintel reports that on November 13, 2024, TD Cowen downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) from ...
Kronos Bio (KRON – Research Report) received a Hold rating and price target from TD Cowen analyst Tyler Van Buren yesterday. The ...
TD Cowen analyst William Katz maintained a Hold rating on Blue Owl Capital (OWL – Research Report) today and set a price target of ...